
Robert B. Mondesi
Examiner (ID: 1064)
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1653, 1652, 1645 |
| Total Applications | 430 |
| Issued Applications | 174 |
| Pending Applications | 97 |
| Abandoned Applications | 165 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6912275
[patent_doc_number] => 20050176033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Mutant phosphoribosylpyrophosphate synthetase and method for producing L-histidine'
[patent_app_type] => utility
[patent_app_number] => 10/984821
[patent_app_country] => US
[patent_app_date] => 2004-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5771
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10984821
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/984821 | Mutant phosphoribosylpyrophosphate synthetase and method for producing L-histidine | Nov 9, 2004 | Abandoned |
Array
(
[id] => 6990915
[patent_doc_number] => 20050089952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Apparatuses and processes for increasing protein PEGylation reaction yields'
[patent_app_type] => utility
[patent_app_number] => 10/971748
[patent_app_country] => US
[patent_app_date] => 2004-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4689
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10971748
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/971748 | Apparatuses and processes for increasing protein PEGylation reaction yields | Oct 20, 2004 | Abandoned |
Array
(
[id] => 511354
[patent_doc_number] => 07196171
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-27
[patent_title] => 'Alströem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alströem syndrome'
[patent_app_type] => utility
[patent_app_number] => 10/973045
[patent_app_country] => US
[patent_app_date] => 2004-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 12
[patent_no_of_words] => 4548
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/196/07196171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10973045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/973045 | Alströem syndrome gene, gene variants, expressed protein and methods of diagnosis for Alströem syndrome | Oct 19, 2004 | Issued |
Array
(
[id] => 6944333
[patent_doc_number] => 20050196382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-08
[patent_title] => 'Antiviral oligonucleotides targeting viral families'
[patent_app_type] => utility
[patent_app_number] => 10/969812
[patent_app_country] => US
[patent_app_date] => 2004-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 57
[patent_no_of_words] => 35839
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20050196382.pdf
[firstpage_image] =>[orig_patent_app_number] => 10969812
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/969812 | Antiviral oligonucleotides targeting viral families | Oct 18, 2004 | Abandoned |
Array
(
[id] => 589841
[patent_doc_number] => 07435717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-14
[patent_title] => 'Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes'
[patent_app_type] => utility
[patent_app_number] => 10/967061
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 27
[patent_no_of_words] => 21918
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/435/07435717.pdf
[firstpage_image] =>[orig_patent_app_number] => 10967061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/967061 | Pharmaceutical formulations, methods, and dosing regimens for the treatment and prevention of acute coronary syndromes | Oct 14, 2004 | Issued |
Array
(
[id] => 517036
[patent_doc_number] => 07189521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Claudin polypeptides, polynucleotides, and methods of making and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/965972
[patent_app_country] => US
[patent_app_date] => 2004-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31557
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189521.pdf
[firstpage_image] =>[orig_patent_app_number] => 10965972
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/965972 | Claudin polypeptides, polynucleotides, and methods of making and use thereof | Oct 14, 2004 | Issued |
Array
(
[id] => 5813209
[patent_doc_number] => 20060083769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Method and apparatus for preparing bone'
[patent_app_type] => utility
[patent_app_number] => 10/964950
[patent_app_country] => US
[patent_app_date] => 2004-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8005
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20060083769.pdf
[firstpage_image] =>[orig_patent_app_number] => 10964950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/964950 | Method and apparatus for preparing bone | Oct 13, 2004 | Abandoned |
Array
(
[id] => 6990875
[patent_doc_number] => 20050089912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-28
[patent_title] => 'Alternatively spliced isoforms of nuclear factor kappa-B, subunit 1 (NFKB1)'
[patent_app_type] => utility
[patent_app_number] => 10/960409
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15495
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0089/20050089912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10960409
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/960409 | Alternatively spliced isoforms of nuclear factor kappa-B, subunit 1 (NFKB1) | Oct 5, 2004 | Abandoned |
Array
(
[id] => 7163949
[patent_doc_number] => 20050085622
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Method for modifying protein or peptide C-terminal'
[patent_app_type] => utility
[patent_app_number] => 10/958298
[patent_app_country] => US
[patent_app_date] => 2004-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4676
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085622.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958298
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958298 | Method for modifying protein or peptide C-terminal | Oct 5, 2004 | Issued |
Array
(
[id] => 7143882
[patent_doc_number] => 20050118626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Novel human collagen proteins and polynucleotides encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/958858
[patent_app_country] => US
[patent_app_date] => 2004-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9725
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118626.pdf
[firstpage_image] =>[orig_patent_app_number] => 10958858
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/958858 | Novel human collagen proteins and polynucleotides encoding the same | Oct 4, 2004 | Abandoned |
Array
(
[id] => 7237936
[patent_doc_number] => 20050080051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-14
[patent_title] => 'Charged phospholipid compositions and methods for their use'
[patent_app_type] => utility
[patent_app_number] => 10/956065
[patent_app_country] => US
[patent_app_date] => 2004-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8728
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0080/20050080051.pdf
[firstpage_image] =>[orig_patent_app_number] => 10956065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/956065 | Charged phospholipid compositions and methods for their use | Oct 3, 2004 | Issued |
Array
(
[id] => 616577
[patent_doc_number] => 07144989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-05
[patent_title] => 'Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/957200
[patent_app_country] => US
[patent_app_date] => 2004-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 15660
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/144/07144989.pdf
[firstpage_image] =>[orig_patent_app_number] => 10957200
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/957200 | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof | Sep 30, 2004 | Issued |
Array
(
[id] => 6996325
[patent_doc_number] => 20050136103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Compositions capable of facilitating penetration across a biological barrier'
[patent_app_type] => utility
[patent_app_number] => 10/942300
[patent_app_country] => US
[patent_app_date] => 2004-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19227
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136103.pdf
[firstpage_image] =>[orig_patent_app_number] => 10942300
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/942300 | Compositions capable of facilitating penetration across a biological barrier | Sep 15, 2004 | Abandoned |
Array
(
[id] => 7163048
[patent_doc_number] => 20050085410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Artificial oxygen carrier and production method thereof'
[patent_app_type] => utility
[patent_app_number] => 10/927675
[patent_app_country] => US
[patent_app_date] => 2004-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6944
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085410.pdf
[firstpage_image] =>[orig_patent_app_number] => 10927675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/927675 | Artificial oxygen carrier and production method thereof | Aug 26, 2004 | Issued |
Array
(
[id] => 6918117
[patent_doc_number] => 20050095678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Novel rat calcium channel subunits and related probes, cell lines and methods'
[patent_app_type] => utility
[patent_app_number] => 10/924081
[patent_app_country] => US
[patent_app_date] => 2004-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13250
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20050095678.pdf
[firstpage_image] =>[orig_patent_app_number] => 10924081
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/924081 | Rat calcium channel subunits and related probes, cell lines and methods | Aug 22, 2004 | Issued |
Array
(
[id] => 7215655
[patent_doc_number] => 20050054574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Methods for modulating a drug-related effect or behavior'
[patent_app_type] => utility
[patent_app_number] => 10/913697
[patent_app_country] => US
[patent_app_date] => 2004-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21159
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054574.pdf
[firstpage_image] =>[orig_patent_app_number] => 10913697
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/913697 | Methods for modulating a drug-related effect or behavior | Aug 4, 2004 | Issued |
Array
(
[id] => 7089621
[patent_doc_number] => 20050009734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-13
[patent_title] => 'Avian sternal cartilage composition and method of administering'
[patent_app_type] => utility
[patent_app_number] => 10/909204
[patent_app_country] => US
[patent_app_date] => 2004-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2521
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20050009734.pdf
[firstpage_image] =>[orig_patent_app_number] => 10909204
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/909204 | Avian sternal cartilage composition and method of administering | Jul 29, 2004 | Abandoned |
Array
(
[id] => 7127838
[patent_doc_number] => 20050059582
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Use of soluble P-selectin and anthrax lethal toxin'
[patent_app_type] => utility
[patent_app_number] => 10/902489
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4124
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20050059582.pdf
[firstpage_image] =>[orig_patent_app_number] => 10902489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/902489 | Use of soluble P-selectin and anthrax lethal toxin | Jul 28, 2004 | Abandoned |
Array
(
[id] => 7027282
[patent_doc_number] => 20050020809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases'
[patent_app_type] => utility
[patent_app_number] => 10/901243
[patent_app_country] => US
[patent_app_date] => 2004-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 28114
[patent_no_of_claims] => 133
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20050020809.pdf
[firstpage_image] =>[orig_patent_app_number] => 10901243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/901243 | Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases | Jul 28, 2004 | Abandoned |
Array
(
[id] => 872655
[patent_doc_number] => 07361736
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-22
[patent_title] => 'Family 44 xyloglucanases'
[patent_app_type] => utility
[patent_app_number] => 10/896555
[patent_app_country] => US
[patent_app_date] => 2004-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21966
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/361/07361736.pdf
[firstpage_image] =>[orig_patent_app_number] => 10896555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/896555 | Family 44 xyloglucanases | Jul 21, 2004 | Issued |